Just three months after 2025, uncertainty has been a common theme for global financial markets. The cryptocurrency sector is no different, and prices are stagnant amid the vulnerability of the macroeconomics. However, Cardano has recently reversed the 14% drop, turning its eyes with all eyes on where the ADA is heading next.
Cardano has firmly established itself in a collection of tokens that could surge throughout the year. Assets like Solana (Sol) and Ripple (XRP) concluded the list. However, if the ADA can take on critical levels, it could be on track to outweigh those competing assets.
Cardano finishes the week by jumping 4% to 4%.
Many financial markets are in uncertainty as the global economy faces an increasing number of headwinds. The US and China are building a full-scale trade war as they control investors’ actions this year. Whether it’s the stock market or the crypto, these facts cannot be denied.
However, things have turned a bit to close the week of digital assets. Specifically, Cardano was able to reverse the 14% drop as all eyes are on where the ADA is heading next. In fact, according to Coinmarketcap, tokens have fallen by more than 5% over the past seven days. Still, it rose 5% for the week, trading at the $0.62 level.
So, what’s next for Cardaon? Well, a lot of it depends on how it reacts to inversion. If an asset can reach $0.657 with a strong volume, expert Fibonacci’s predictions show that it can be split upwards to the $0.72 mark. However, if you are unable to break through the resistance zone located in late February, you risk a low drop of as much as $0.55.
Overall, there are bullish feelings in many people, including Concodex. The cryptocurrency price prediction platform won a median target of $0.64 in April at the ADA. However, this month we projected a high-end forecast of $0.74, an increase of 19% from that position. It coincides with Fibonacci’s outlook and could precede a bullish turn. In fact, they are noting that their assets have a 69% advantage and that there is a $1 cap on performance in 2025.